pak 104p has been researched along with carbocyanines in 1 studies
Studies (pak 104p) | Trials (pak 104p) | Recent Studies (post-2010) (pak 104p) | Studies (carbocyanines) | Trials (carbocyanines) | Recent Studies (post-2010) (carbocyanines) |
---|---|---|---|---|---|
16 | 0 | 0 | 5,287 | 4 | 2,147 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Minderman, H; Minderman, MD; Rustum, YM; Slovak, ML; Toth, K; Vanhoefer, U; Wrzosek, C; Yin, MB | 1 |
1 other study(ies) available for pak 104p and carbocyanines
Article | Year |
---|---|
DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carbocyanines; Cyclic P-Oxides; Doxorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Fluorescent Dyes; Humans; Neoplasm Proteins; Nicotinic Acids; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1996 |